Tesamorelin × bioedgeresearchlabs.com — lab test, February 2026
COA 260970 matches MDx BioAnalytical Laboratory's public record. So this test doesn't rest on our review alone — the lab confirms it too.
260970Test results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 10 mg · Lab measured 10.11 mg
101% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 2.5 mg using the measured mass, against 2.5 mg on the label — 1% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | 260970 |
|---|---|
| Portal lookup | ✓ Lab-verified |
| Checked | 14 Aug 2026date taken from the record, not from a logged check |
| Checked by | Peptigrity staff, against the lab's portal |
| PDF vs portal | MDx BioAnalytical Laboratory's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of Tesamorelin from bioedgeresearchlabs.com, performed by MDx BioAnalytical Laboratory on February 11, 2026. Reported purity: 99.74%. Net content: 10.11 mg against 10 mg labeled (101% of label). Endotoxins: PASS (≤0.05 EU/mL). Batch 260202TM103. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Other lots of Tesamorelin from bioedgeresearchlabs.com
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| 061826TESA20 | 3 Aug 2026 | Kovera Labs | 99.751% | 111% | ✓ Lab-verified |
| 062026TES10 | 3 Aug 2026 | Kovera Labs | 99.703% | 114% | ✓ Lab-verified |
| 260112TM103 | 16 Jan 2026 | MDx BioAnalytical Laboratory | 99.79% | 101% | ✓ Lab-verified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion